Research map: Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance

Back to the article

Papers in this map

  1. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method · Ting‐Chao Chou · 2010 · 5857 citations · Cited by this paper
  2. Discovery of NAT-6-321056 as a novel modulator of VEGFR2 signaling to suppress tumor angiogenesis · Xiao Lei · 2026 · Cites this paper
  3. Tailored HER2 ECD mRNA-LNP vaccines boost CD8+ T cell-mediated antitumor immunity for HER2-positive tumor suppression · 2026 · Related
  4. Guidelines for the welfare and use of animals in cancer research · Paul Workman · 2010 · 1469 citations · Cited by this paper
  5. Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies · 2026 · Related
  6. Mitochondrial composition and function under the control of hypoxia · Dominik Christian Fuhrmann · 2017 · 663 citations · Cited by this paper
  7. Low dose radiation induces new protein synthesis that promotes cancer radiotherapy resistance · 2026 · Related
  8. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention · Lisa M. Butler · 2020 · 657 citations · Cited by this paper
  9. Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma · 2026 · Related
  10. The multi-factorial nature of clinical multidrug resistance in cancer · Yehuda G. Assaraf · 2019 · 541 citations · Cited by this paper
  11. ZBED6-Driven Nucleotide Metabolic Reprogramming Improves Sensitivity to anti-PD1 Therapy in NK/T Cell Lymphoma · 2026 · Related
  12. mTORC2 Promotes Tumorigenesis via Lipid Synthesis · Yakir Guri · 2017 · 421 citations · Cited by this paper
  13. PRKCA and ABCB1 dual-enriched exosomes are key drivers of drug resistance in chronic myeloid leukemia · 2026 · Related
  14. The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation · Junichi Tsukada · 2011 · 333 citations · Cited by this paper
  15. Mechanistic analysis on epigenetic programming of tumor drug resistance · 2026 · Related
  16. Molecular mechanisms of platinum‑based chemotherapy resistance in ovarian cancer (Review) · Ling Yang · 2022 · 311 citations · Cited by this paper
  17. NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma · 2026 · Related
  18. A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study · Christian Holubarsch · 2007 · 296 citations · Cited by this paper
  19. Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway · 2026 · Related
  20. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets · Joanna Kopecka · 2019 · 293 citations · Cited by this paper
  21. Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations · 2024 · Related
  22. Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα · Mounia Tahri-Joutey · 2021 · 254 citations · Cited by this paper
  23. Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance · Jing‐Quan Wang · 2021 · 239 citations · Cited by this paper
  24. PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy · Iris Chiara Salaroglio · 2017 · 216 citations · Cited by this paper
  25. Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of β-oxidation · Cong-Hui Yao · 2018 · 211 citations · Cited by this paper
  26. The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations · Roddy S. O’Connor · 2018 · 211 citations · Cited by this paper
  27. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance · Emily L. Giddings · 2021 · 208 citations · Cited by this paper
  28. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer · Lei Ma · 2024 · 206 citations · Cited by this paper
  29. Diphenyleneiodonium Inhibits the Cell Redox Metabolism and Induces Oxidative Stress · Chiara Riganti · 2004 · 204 citations · Cited by this paper
  30. Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters · Andaleeb Sajid · 2023 · 203 citations · Cited by this paper
  31. CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases · Cynthia A. Zahnow · 2009 · 185 citations · Cited by this paper
  32. Impact of cancer metabolism on therapy resistance – Clinical implications · Ana Cristina Gonçalves · 2021 · 167 citations · Cited by this paper
  33. Overexpression of C/EBP -LIP, a Naturally Occurring, Dominant-Negative Transcription Factor, in Human Breast Cancer · C. A. Cynthia A. · 1997 · 141 citations · Cited by this paper
  34. Lipostar, a Comprehensive Platform-Neutral Cheminformatics Tool for Lipidomics · Laura Goracci · 2017 · 139 citations · Cited by this paper
  35. PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation · Qianqian Du · 2019 · 139 citations · Cited by this paper
  36. Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain · Alice M. Coughlan · 2016 · 137 citations · Cited by this paper
  37. Physiologic disruption and metabolic reprogramming in infection and sepsis · Katharina L. Willmann · 2024 · 129 citations · Cited by this paper
  38. Understanding and overcoming multidrug resistance in cancer · Minghua Ge · 2025 · 119 citations · Cited by this paper
  39. CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing · Zheng Liu · 2023 · 111 citations · Cited by this paper

Source: OpenAlex (CC0)